Boston, Massachusetts
May 16-17, 2019

BERNARDO TRIGATTI — HDL and SR-B1 in cardiovascular disease: Atherosclerosis and beyond

CHIEKO MINEO — SR-B1 and atherosclerosis: a new paradigm for an old story

CATHERINE MARTEL — Extracellular vesicles at the Heart of Lymphatic function in RCT

DARCY KNAACK — The roles of SR-BI and CD36 in maintenance of macrophage cholesterol homeostasis

JOHN T WILKINS — Associations Between Apolipoprotein A-I Proteoforms and HDL Efflux Capacity

DAISY SAHOO — The importance of HDL clearance: Lessons from Dr. Jekyll and Mr. Hyde

BELA ASZTALOS — Analyses on HDL Composition and Function

HENRY POWNALL — Serum Opacity Factor

PASCAL BERNATCHEZ — HDL, LDL and muscular dystrophy

AMANDA RIBEIRO MARTINS DA SILVA — High-Density Lipoprotein Subclasses Mapping by Targeted Quantitative Proteomics

JACOB BARBER — Association of Exercise-Induced Changes in Cholesterol Efflux Capacity with Changes in the HDL Proteome

GREGORY C. SHEARER — Eicosapentaenoate and other polyunsaturated fatty acids in HDL function

ANGELA M. ZIVKOVIC — Effects of Prolonged Fasting on Microbiome and HDL

UWE TIETGE — Impact of intestinal microbiota on Reverse Cholesterol Transport